<VariationArchive VariationID="636047" VariationName="NM_014249.4(NR2E3):c.481del (p.Thr161fs)" VariationType="Deletion" Accession="VCV000636047" Version="34" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-29" DateCreated="2019-07-21" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="623884" VariationID="636047">
      <GeneList>
        <Gene Symbol="NR2E3" FullName="nuclear receptor subfamily 2 group E member 3" GeneID="10002" HGNC_ID="HGNC:7974" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="71810554" stop="71818253" display_start="71810554" display_stop="71818253" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="72102893" stop="72110599" display_start="72102893" display_stop="72110599" Strand="+" />
          </Location>
          <OMIM>604485</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014249.4(NR2E3):c.481del (p.Thr161fs)</Name>
      <CanonicalSPDI>NC_000015.10:71812085:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="71812086" stop="71812086" display_start="71812086" display_stop="71812086" variantLength="1" positionVCF="71812085" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="72104426" stop="72104426" display_start="72104426" display_stop="72104426" variantLength="1" positionVCF="72104425" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T161fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.71812086del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.71812086del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.72104426del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.72104426del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009113.2" sequenceAccession="NG_009113" sequenceVersion="2" change="g.6532del">
            <Expression>NG_009113.2:g.6532del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014249.4" sequenceAccession="NM_014249" sequenceVersion="4" change="c.481del" MANESelect="true">
            <Expression>NM_014249.4:c.481del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055064.1" sequenceAccession="NP_055064" sequenceVersion="1" change="p.Thr161fs">
            <Expression>NP_055064.1:p.Thr161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016346.4" sequenceAccession="NM_016346" sequenceVersion="4" change="c.481del">
            <Expression>NM_016346.4:c.481del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057430.1" sequenceAccession="NP_057430" sequenceVersion="1" change="p.Thr161fs">
            <Expression>NP_057430.1:p.Thr161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014249.4" sequenceAccession="NM_014249" sequenceVersion="4" change="c.481delA" MANESelect="true">
            <Expression>NM_014249.4:c.481delA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014249.3" sequenceAccession="NM_014249" sequenceVersion="3" change="c.481delA">
            <Expression>NM_014249.3:c.481delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="759339012" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00005" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00006" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00016" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014249.4(NR2E3):c.481del (p.Thr161fs) AND Retinal dystrophy" Accession="RCV001075832" Version="3">
        <ClassifiedConditionList TraitSetID="12366">
          <ClassifiedCondition DB="MedGen" ID="C0854723">Retinal dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014249.4(NR2E3):c.481del (p.Thr161fs) AND Retinitis pigmentosa" Accession="RCV000787629" Version="1">
        <ClassifiedConditionList TraitSetID="6496">
          <ClassifiedCondition DB="MedGen" ID="C0035334">Retinitis pigmentosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-04-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014249.4(NR2E3):c.481del (p.Thr161fs) AND not provided" Accession="RCV001059829" Version="26">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014249.4(NR2E3):c.481del (p.Thr161fs) AND Goldmann-Favre syndrome" Accession="RCV001275375" Version="2">
        <ClassifiedConditionList TraitSetID="1551">
          <ClassifiedCondition DB="MedGen" ID="C0339541">Goldmann-Favre syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014249.4(NR2E3):c.481del (p.Thr161fs) AND Enhanced S-cone syndrome" Accession="RCV003467321" Version="2">
        <ClassifiedConditionList TraitSetID="1549">
          <ClassifiedCondition DB="MedGen" ID="C1849394">Enhanced S-cone syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014249.4(NR2E3):c.481del (p.Thr161fs) AND NR2E3-related disorder" Accession="RCV004535917" Version="1">
        <ClassifiedConditionList TraitSetID="33557">
          <ClassifiedCondition DB="MedGen" ID="CN239387">NR2E3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-01" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2019-07-21" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15459973</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18436841</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22711506</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30718709</ID>
        </Citation>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1549" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2085" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Enhanced S-cone syndrome</ElementValue>
                <XRef ID="MONDO:0100288" DB="MONDO" />
                <XRef ID="MONDO:0009989" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ESCS</ElementValue>
                <XRef Type="MIM" ID="268100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10781" />
                <XRef ID="10781" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53540" DB="Orphanet" />
              <XRef ID="C1849394" DB="MedGen" />
              <XRef ID="MONDO:0100288" DB="MONDO" />
              <XRef Type="MIM" ID="268100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1551" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8965" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Goldmann-Favre syndrome</ElementValue>
                <XRef ID="MONDO:0100289" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10781" />
                <XRef ID="10781" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53540" DB="Orphanet" />
              <XRef ID="C0339541" DB="MedGen" />
              <XRef ID="MONDO:0100289" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6496" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tapetoretinal degeneration</ElementValue>
                <XRef ID="HP:0000547" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa</ElementValue>
                <XRef ID="CN038210" DB="ADAM" />
                <XRef ID="Retinitis+pigmentosa/6248" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019200" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS268000" DB="OMIM" />
                <XRef ID="28835009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP</ElementValue>
                <XRef Type="MIM" ID="268000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5694" />
                <XRef ID="5694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Autosomal dominant, autosomal recessive and X linked inheritance</Attribute>
                <XRef ID="GTR000561973" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <ID Source="PubMed">22234150</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Bakondi et al., 2015">
                <ID Source="PubMed">26666451</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C0035334" DB="MedGen" />
              <XRef ID="D012174" DB="MeSH" />
              <XRef ID="MONDO:0019200" DB="MONDO" />
              <XRef Type="MIM" ID="268000" DB="OMIM" />
              <XRef Type="Phenotypic series" ID="PS268000" DB="OMIM" />
              <XRef Type="secondary" ID="HP:0000547" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36584" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NR2E3-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR2E3-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NR2E3-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239387" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12366" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18440" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinal dystrophy</ElementValue>
                <XRef ID="HP:0000556" DB="Human Phenotype Ontology" />
                <XRef ID="314407005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inherited retinal dystrophy</ElementValue>
                <XRef ID="MONDO:0019118" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18916" />
                <XRef ID="18916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="71862" DB="Orphanet" />
              <XRef ID="C0854723" DB="MedGen" />
              <XRef ID="D058499" DB="MeSH" />
              <XRef ID="MONDO:0019118" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000556" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007736" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007910" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007974" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007982" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1812391" SubmissionDate="2018-12-05" DateLastUpdated="2023-09-03" DateCreated="2019-07-21">
        <ClinVarSubmissionID localKey="NM_014249.3:c.481del|MedGen:C0035334" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000926614" DateUpdated="2023-09-03" DateCreated="2019-07-21" Type="SCV" Version="2" SubmitterName="Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet" OrgID="1147" OrganizationCategory="laboratory" OrgAbbreviation="MGL_KC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">30718709</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR2E3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014249.3:c.481del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Retinitis pigmentosa</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0035334" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">30718709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30718709</ID>
        </Citation>
        <StudyName>VeluxRD</StudyName>
        <StudyDescription>Investigation of 124 genes associated with retinal dystrophies</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB4878608</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2444789" SubmissionDate="2019-10-15" DateLastUpdated="2020-04-18" DateCreated="2020-04-18">
        <ClinVarSubmissionID localKey="NM_014249.3:c.481del|Retinal dystrophy" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001241470" DateUpdated="2020-04-18" DateCreated="2020-04-18" Type="SCV" Version="1" SubmitterName="Blueprint Genetics" OrgID="500188" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Blueprint Genetics Variant Classification Scheme</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8okxtmpf/blueprint_genetics_variant_classification_scheme.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014249.3:c.481del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Retinal dystrophy</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>My Retina Tracker patient</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB6252865</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2875780" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_014249.4:c.481delA|Goldmann-Favre syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001460505" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014249.4:c.481delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Goldmann-Favre syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2389969" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4925011|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001224477" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15459973</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27522502</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15459973</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18436841</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22711506</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr161Hisfs*18) in the NR2E3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NR2E3 are known to be pathogenic (PMID: 15459973, 27522502). This variant is present in population databases (rs759339012, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with autosomal recessive enhanced S-cone syndrome (PMID: 15459973, 18436841, 22711506). ClinVar contains an entry for this variant (Variation ID: 636047). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR2E3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.72104426del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2639013" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-06-08">
        <ClinVarSubmissionID localKey="103163|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001334797" DateUpdated="2024-07-15" DateCreated="2020-06-08" Type="SCV" Version="22" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>NR2E3: PM3:Very Strong, PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR2E3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="C" referenceAllele="CA" start="72104425" stop="72104426" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7699493" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="3577782|NR2E3-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004117158" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NR2E3 c.481delA variant is predicted to result in a frameshift and premature protein termination (p.Thr161Hisfs*18). This variant was reported in the homozygous and compound heterozygous state in individuals with NR2E3-related diseases (see for example - Wright et al. 2004. PubMed ID: 15459973). This variant is reported in 0.017% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-72104425-CA-C). Frameshift variants in NR2E3 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR2E3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014249.3:c.481delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NR2E3-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7843133" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_014249.4:c.481del|OMIM:268100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004191594" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014249.4:c.481del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2389969" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2444789" TraitType="Disease" MappingType="Name" MappingValue="Retinal dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0854723" Name="Retinal dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7843133" TraitType="Disease" MappingType="XRef" MappingValue="268100" MappingRef="OMIM">
        <MedGen CUI="C1849394" Name="Enhanced S-cone syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2875780" TraitType="Disease" MappingType="Name" MappingValue="Goldmann-Favre syndrome" MappingRef="Preferred">
        <MedGen CUI="C0339541" Name="Goldmann-Favre syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7699493" TraitType="Disease" MappingType="Name" MappingValue="NR2E3-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239387" Name="NR2E3-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2639013" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1812391" TraitType="Disease" MappingType="Name" MappingValue="Retinitis pigmentosa" MappingRef="Preferred">
        <MedGen CUI="C0035334" Name="Retinitis pigmentosa" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

